The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 28, 2010

Filed:

Aug. 23, 2006
Applicants:

Kevin D. Mccormick, Basking Ridge, NJ (US);

Christopher W. Boyce, Flemington, NJ (US);

Robert G. Aslanian, Rockaway, NJ (US);

Neng-yang Shih, Warren, NJ (US);

Salem Fevrier, Cranford, NJ (US);

Pietro Mangiaracina, Monsey, NY (US);

Chia-yu Huang, West Windsor, NY (US);

BO Liang, Lawrenceville, NJ (US);

Rong-qiang Liu, Kendall Park, NJ (US);

Huagang LU, Plainsboro, NJ (US);

Inventors:

Kevin D. McCormick, Basking Ridge, NJ (US);

Christopher W. Boyce, Flemington, NJ (US);

Robert G. Aslanian, Rockaway, NJ (US);

Neng-Yang Shih, Warren, NJ (US);

Salem Fevrier, Cranford, NJ (US);

Pietro Mangiaracina, Monsey, NY (US);

Chia-Yu Huang, West Windsor, NY (US);

Bo Liang, Lawrenceville, NJ (US);

Rong-Qiang Liu, Kendall Park, NJ (US);

Huagang Lu, Plainsboro, NJ (US);

Assignee:

Schering-Plough Corporation, Kenilworth, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/50 (2006.01); C07D 233/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

In its many embodiments, the present invention provides a novel class of indolines as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.


Find Patent Forward Citations

Loading…